Literature DB >> 8624886

Prevalence of hemoglobin S and beta-thalassemia in northern Jordan.

E I Sunna1, N S Gharaibeh, D D Knapp, N A Bashir.   

Abstract

OBJECTIVE: The aim of this study was to determine the incidence of HbS and beta-thalassemia in the Northern Jordan. STUDY
DESIGN: The investigation targeted 3 areas of Northern Jordan. Blood samples from 2,290 volunteers were evaluated to determine the prevalence of HbS and beta-thalassemia by preparing a hemolysate for cellulose acetate electrophoresis. An additional 568 newborn samples were collected from the umbilical and analyzed for the presence of HbS using electrophoresis.
RESULTS: The overall prevalence of HbS and beta-thalassemia was 4.45% and 5.93%, respectively. The incidence of sickle cell trait in the newborn sample was 3.17%. The prevalence of both HbS and beta-thalassemia was higher in the Al-Gor area in comparison to Ajloun and Irbid.
CONCLUSION: A better understanding of the demographics of these diseases has the potential to aid in the more efficient utilization of health care resources and improved planning and provision of health care services.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624886     DOI: 10.1111/j.1447-0756.1996.tb00929.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  4 in total

1.  Epidemiological profile of common haemoglobinopathies in Arab countries.

Authors:  Hanan A Hamamy; Nasir A S Al-Allawi
Journal:  J Community Genet       Date:  2012-12-08

2.  Sickle Cell Disease in Jordan: The Experience of a Major Referral Center.

Authors:  Raida I Oudat; Heba S Abualruz; Nazih Kh Abu Al-Shiek; Eman A Al-Mashaqba; Rawan A Al-Hiari; Hala A Alsoukhni; Ma'mon A Abu Hammad
Journal:  Med Arch       Date:  2021-02

Review 3.  Sickle cell disease in Middle East Arab countries.

Authors:  Mohsen A F El-Hazmi; Ali M Al-Hazmi; Arjumand S Warsy
Journal:  Indian J Med Res       Date:  2011-11       Impact factor: 2.375

4.  Central macular thickness in patients with sickle cell disease and no signs of retinopathy: a cross-sectional study of Jordanian patients.

Authors:  Nakhleh E Abu-Yaghi; Ahmad M AlNawaiseh; Issam M Khourshid; Tala J AlRawashdeh; Majd M Al Rawashdeh; Ayat M Zghoul; Abdallah N Shafagoj; Yousif A Alomairi; Sana' M Muhsen; SaifAldeen S AlRyalat
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.